☆ 4.7 Article

Lectin from Triticum vulgaris (WGA) Inhibits Infection with SARS-CoV-2 and Its Variants of Concern Alpha and Beta

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Natural products may interfere with SARS-CoV-2 attachment to the host cell

Abdo A. Elfiky

Summary: The study tested natural product compounds against the HSPA5 substrate-binding domain beta (SBD beta), the recognition site for the SARS-CoV-2 spike, showing high to moderate binding affinity for phytoestrogens and estrogens which may interfere with SARS-CoV-2 attachment to stressed cells, potentially serving as anti-COVID-19 agents for high-risk individuals such as elders, cancer patients, and front-line medical staff.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Add to Collection

Review Cell Biology

Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms: A systematic review of in vitro and in vivo studies

Simin Seyedpour et al.

Summary: This study systematically evaluated recent in vitro and in vivo investigations targeting SARS-CoV-2 cell entry, finding that SARS-CoV-2 primarily enters host cells through the S protein utilizing ACE2 or CD147 as receptors. Targeted therapy strategies against SARS-CoV-2 cell entry mechanisms mainly focus on targeting virus receptors on the host, neutralizing spike protein, interfering with virus fusion to host cells, and disrupting endosomal and non-endosomal dependent pathways.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Add to Collection

Article Chemistry, Analytical

N- and O-Glycosylation of the SARS-CoV-2 Spike Protein

Miloslav Sanda et al.

Summary: The outbreak of the Covid-19 pandemic has caused the current global health crisis, prompting the need for detailed studies on SARS-CoV-2 proteins to develop effective antiviral compounds and vaccines. The glycosylation of the spike (S) protein plays a significant role in its proteolytic activation, expanding the current knowledge in this area.

ANALYTICAL CHEMISTRY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets

Isabella Romeo et al.

Summary: The COVID-19 pandemic caused by the SARS-CoV-2 virus has led to significant health issues worldwide. Efforts to find effective treatments for COVID-19 are ongoing, including the exploration of repurposing natural compounds. Some natural compounds are currently being tested in clinical trials for their potential role in preventing and treating COVID-19 infections.

MOLECULES (2021)

Add to Collection

Article Medicine, General & Internal

Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results

Summary: The authors of the study reported the interim results of using four repurposed antiviral drugs (remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a) in hospitalized COVID-19 patients. The study showed that these drug regimens had little or no effect on overall mortality, initiation of ventilation, and duration of hospital stay.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Mechanism of SARS-CoV-2 polymerase stalling by remdesivir

Goran Kokic et al.

Summary: Remdesivir is the only FDA-approved drug for treating COVID-19 patients, working by inhibiting the RNA-dependent RNA polymerase (RdRp) of coronaviruses. It hinders RNA synthesis and impairs proofreading by the viral 3'-exonuclease, leading to a stalled replication process.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021

Summer E. Galloway et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Editorial Material Medicine, General & Internal

SARS-CoV-2 Vaccines

C. Buddy Creech et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Nutrition & Dietetics

High-dose intravenous vitamin C attenuates hyperinflammation in severe coronavirus disease 2019

Guozhi Xia et al.

Summary: This retrospective cohort study found that the levels of inflammatory markers significantly decreased in severe COVID-19 patients treated with HIVC, with a higher reduction percentage compared to those without HIVC treatment. Multiple linear regression analysis indicated that HIVC treatment was independently associated with reductions in inflammatory marker levels.

NUTRITION (2021)

Add to Collection

Article Multidisciplinary Sciences

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Dami A. Collier et al.

Summary: The B.1.1.7 variant of SARS-CoV-2 exhibited reduced neutralization by vaccines and antibodies from recovered COVID-19 patients, with a more substantial loss seen when introducing the E484K mutation. This mutation poses a threat to the efficacy of the BNT162b2 vaccine.

NATURE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

Constantinos Kurt Wibmer et al.

Summary: The SARS-CoV-2 virus in the B.1.351 variant discovered in South Africa can evade neutralization by most antibodies when expressed, but does not affect binding by convalescent plasma. This suggests the potential for reinfection with antigenically distinct variants and predicts reduced efficacy of spike-based vaccines.

NATURE MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in vitro

Martina Morokutti-Kurz et al.

Summary: Iota-carrageenan has shown to inhibit cell entry of SARS-CoV-2 virus and replication, with potential antiviral effects demonstrated in vitro. Clinical studies have also indicated that iota-carrageenan can reduce severity and duration of symptoms caused by various respiratory viruses, suggesting it may be an effective prophylaxis or treatment for SARS-CoV-2 infections.

PLOS ONE (2021)

Add to Collection

Article Multidisciplinary Sciences

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Nicholas G. Davies et al.

Summary: A new variant of SARS-CoV-2 has emerged in England, with a higher reproduction number and potential for large resurgences of COVID-19 cases. Without stringent control measures, it is projected that COVID-19 hospitalizations and deaths in England for the first 6 months of 2021 will exceed those in 2020. The variant has spread globally and exhibited similar transmission increases in Denmark, Switzerland, and the United States.

SCIENCE (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Detection of B.1.351 SARS-CoV-2 Variant Strain - Zambia, December 2020

Mulenga Mwenda et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Review Microbiology

SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention

Alessio Danilo Inchingolo et al.

Summary: This study evaluated the effect of adjuvant therapies and supplements for SARS-CoV-2 infection, with some substances showing significant benefits for improving the immune system, acting as potential inhibitor molecules, and enhancing the prognosis of long hauler patients.

MICROORGANISMS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Molecular Mechanisms Behind Anti SARS-CoV-2 Action of Lactoferrin

Mattia Miotto et al.

Summary: Lactoferrin is believed to interfere with the invasion of SARS-CoV-2 into cells by potentially binding to sialic acid on the host cell membrane, and may compete with ACE2 for binding to the spike protein.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Add to Collection

Article Microbiology

Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization

Pengfei Wang et al.

Summary: The emerging Brazilian variant P.1 shows increased resistance to antibody neutralization, posing a threat to current antibody therapies, but has less impact on the effectiveness of protective vaccines.

CELL HOST & MICROBE (2021)

Add to Collection

Article Multidisciplinary Sciences

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

Erik Volz et al.

Summary: Genetic and testing data from England indicate that the SARS-CoV-2 variant B.1.1.7 has a transmission advantage over other lineages, showing a rapid expansion during autumn 2020. Analysis of S gene target failures (SGTF) in community-based diagnostic PCR testing suggests that B.1.1.7 is more transmissible than non-variant of concern lineages and has a significant transmission advantage, with a reproduction number 50% to 100% higher. Additionally, cases of B.1.1.7 appear to include a larger share of under 20-year-olds compared to non-variant cases.

NATURE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Human coronavirus spike protein-host receptor recognition

Lalitha Guruprasad

Summary: There are various types of coronaviruses that can cause respiratory diseases in humans, originating from rodents and bats. SARS-CoV-2, which originated in bats and was transmitted to humans via pangolins, shares a common viral entry mechanism with other animals.

PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2021)

Add to Collection

Article Virology

Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2

Maximilian Grosse et al.

Summary: This study found that quinine exhibited more effective antiviral activity against SARS-CoV-2 with lower toxicity compared to CQN and H-CQN. It showed antiviral activity in different cell lines, indicating its potential as a treatment option for SARS-CoV-2.

VIRUSES-BASEL (2021)

Add to Collection

Article Virology

The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus

Yeong Jun Kim et al.

Summary: A new variant of SARS-CoV-2 B.1.351 lineage is of global concern for its potential increase in transmissibility and resistance to neutralizing antibodies. This study found that the B.1.351 lineage variant showed significantly increased infectivity and enhanced cell-cell fusion compared to the Wuhan strains, particularly with the K417N and E484K mutations. In terms of antibody efficacy, Imdevimab was more effective in neutralizing the B.1.351 lineage pseudoviruses containing specific mutations, compared to Casirivimab.

VIRUSES-BASEL (2021)

Add to Collection

Article Chemistry, Medicinal

Griffithsin and Carrageenan Combination Results in Antiviral Synergy against SARS-CoV-1 and 2 in a Pseudoviral Model

Sahar Alsaidi et al.

Summary: The study found that iota and lambda carrageenan exhibit the most potent antiviral activity against SARS-CoV-1 and SARS-CoV-2, and combinations of griffithsin and carrageenan show synergistic effects, including against recent SARS-CoV-2 mutations. The combination is a promising candidate for preventing or treating infections by SARS-CoV-1 and SARS-CoV-2.

MARINE DRUGS (2021)

Add to Collection

Article Multidisciplinary Sciences

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delphine Planas et al.

Summary: The SARS-CoV-2 B.1.617 Delta variant, first identified in India in 2020, has become dominant in some regions and is spreading to many countries. This variant shows resistance to certain monoclonal antibodies and antibodies in convalescent sera, as well as reduced neutralization by some COVID-19 vaccines. Administration of two doses of the vaccine is needed for a neutralizing response against the Delta variant.

NATURE (2021)

Add to Collection

Article Multidisciplinary Sciences

Immune response to SARS-CoV-2 variants of concern in vaccinated individuals

Matthias Becker et al.

Summary: This study characterizes the antibody response from vaccinated, infected, and uninfected individuals against emerging variants of concern of SARS-CoV-2, indicating reduced neutralization of a South African isolate. High IgG titers in the saliva of vaccinees suggest reduced transmission potential.

NATURE COMMUNICATIONS (2021)

Add to Collection

Letter Infectious Diseases

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation

Sonia Jangra et al.

LANCET MICROBE (2021)

Add to Collection

Article Immunology

Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study

Li Guo et al.

Summary: This study revealed that there is a cross-reactivity between antibodies against seasonal human coronaviruses and SARS-CoV-2 in COVID-19 patients. Specifically, higher levels of HCoV-OC43 antibodies were found to be associated with disease severity in COVID-19 patients.

EMERGING MICROBES & INFECTIONS (2021)

Add to Collection

Article Infectious Diseases

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Victor M. Corman et al.

EUROSURVEILLANCE (2020)

Add to Collection

Review Health Care Sciences & Services

Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)

Fang Jiang et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2020)

Add to Collection

Article Virology

Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS

Yushun Wan et al.

JOURNAL OF VIROLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Add to Collection

Article Biochemistry & Molecular Biology

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann et al.

CELL (2020)

Add to Collection

Article Multidisciplinary Sciences

Site-specific glycan analysis of the SARS-CoV-2 spike

Yasunori Watanabe et al.

SCIENCE (2020)

Add to Collection

Review Virology

COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis

Long-quan Li et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

Xiuyuan Ou et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Letter Cell Biology

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

Jia Liu et al.

CELL DISCOVERY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Bette Korber et al.

CELL (2020)

Add to Collection

Review Pharmacology & Pharmacy

Turning the Tide: Natural Products and Natural-Product-Inspired Chemicals as Potential Counters to SARS-CoV-2 Infection

Zhonglei Wang et al.

FRONTIERS IN PHARMACOLOGY (2020)

Add to Collection

Review Virology

Natural product-derived phytochemicals as potential agents against coronaviruses: A review

Janice S. Mani et al.

VIRUS RESEARCH (2020)

Add to Collection

Article Medicine, General & Internal

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

Peter Horby et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

A novel method for live imaging of human airway cilia using wheat germ agglutinin

Ryosuke Nakamura et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Multidisciplinary Sciences

Analysis of vitamin D level among asymptomatic and critically ill COVID-19 patients and its correlation with inflammatory markers

Anshul Jain et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Multidisciplinary Sciences

Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A

Ruben J. G. Hulswit et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Add to Collection

Article Oncology

Wheat Germ Agglutinin as a Potential Therapeutic Agent for Leukemia

Bradley Ryva et al.

FRONTIERS IN ONCOLOGY (2019)

Add to Collection

Article Nutrition & Dietetics

Plant Foods, Antioxidant Biomarkers, and the Risk of Cardiovascular Disease, Cancer, and Mortality: A Review of the Evidence

Dagfinn Aune

ADVANCES IN NUTRITION (2019)

Add to Collection

Article Virology

Human coronavirus circulation in the United States 2014-2017

Marie E. Killerby et al.

JOURNAL OF CLINICAL VIROLOGY (2018)

Add to Collection

Article Medicine, General & Internal

Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitis

Christine Graf et al.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2018)

Add to Collection

Article Medicine, General & Internal

Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat

Martina Morokutti-Kurz et al.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2017)

Add to Collection

Article Chemistry, Analytical

Wheat germ agglutinin and Lens culinaris agglutinin sensitized anisotropic silver nanoparticles in detection of bacteria: A simple photometric assay

Mariam V. Mikaelyan et al.

ANALYTICA CHIMICA ACTA (2017)

Add to Collection

Article Pharmacology & Pharmacy

Antiviral lectins: Selective inhibitors of viral entry

Carter A. Mitchell et al.

ANTIVIRAL RESEARCH (2017)

Add to Collection

Article Cell Biology

Wheat germ agglutinin staining as a suitable method for detection and quantification of fibrosis in cardiac tissue after myocardial infarction

B. Emde et al.

EUROPEAN JOURNAL OF HISTOCHEMISTRY (2014)

Add to Collection

Article Multidisciplinary Sciences

Antiviral Lectins from Red and Blue-Green Algae Show Potent In Vitro and In Vivo Activity against Hepatitis C Virus

Yutaka Takebe et al.

PLOS ONE (2013)

Add to Collection

Article Pharmacology & Pharmacy

Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells

Chunxia Wang et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)

Add to Collection

Article Virology

Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae

Barry R. O'Keefe et al.

JOURNAL OF VIROLOGY (2010)

Add to Collection

Article Virology

A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo

Craig W. Day et al.

VIROLOGY (2009)

Add to Collection

Article Oncology

Phase I trial of r viscumin (INN: aviscumine) given subcutaneously in patients with advanced cancer:: A study of the European Organisation for Research and Treatment of Cancer (EORTC protocol number 13001)

Lothar Bergmann et al.

EUROPEAN JOURNAL OF CANCER (2008)

Add to Collection

Article Pharmacology & Pharmacy

Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle

Els Keyaerts et al.

ANTIVIRAL RESEARCH (2007)

Add to Collection

Article Biochemistry & Molecular Biology

Dissecting carbohydrate-Cyanovirin-N binding by structure-guided mutagenesis: functional implications for viral entry inhibition

Laura G. Barrientos et al.

PROTEIN ENGINEERING DESIGN & SELECTION (2006)

Add to Collection

Article Chemistry, Multidisciplinary

WGA-grafted PLGA-nano spheres:: preparation and association with Caco-2 single cells

A Weissenböck et al.

JOURNAL OF CONTROLLED RELEASE (2004)

Add to Collection

Article Microbiology

Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China

Z Zhao et al.

JOURNAL OF MEDICAL MICROBIOLOGY (2003)

Add to Collection

Article Pharmacology & Pharmacy

Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus

LG Barrientos et al.

ANTIVIRAL RESEARCH (2003)

Add to Collection

Article Pharmacology & Pharmacy

Analysis of the interaction between the HIV-Inactivating protein cyanovirin-N and soluble forms of the envelope glycoproteins gp120 and gp41

BR O'Keefe et al.

MOLECULAR PHARMACOLOGY (2000)

Add to Collection

Article Biochemistry & Molecular Biology

Effects of lectins with different carbohydrate-binding specificities on hepatoma, choriocarcinoma, melanoma and osteosarcoma cell lines

HX Wang et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.